Content Preview
Newsday/Optimum Online® subscribers click here for full access
Not a Newsday or Optimum Online® subscriber? Click here
Quest labs pays $302M as part of guilty plea in fraud
A subsidiary of Quest Diagnostics, the New Jersey-based medical testing company, pleaded guilty to a felony charge of misbranding in Brooklyn federal court Wednesday and Quest agreed to pay $302 million to settle charges that it marketed a flawed renal testing kit for kidney dialysis patients that produced inaccurate results. The Justice Department said the $302 million - including a $40-million...
newsday.com is now available at no charge to Newsday and Optimum Online® subscribers. To continue reading, please log in or register now.
-
Already
registered on
newsday.com?
log in -
Already a subscriber
to Newsday or
Optimum Online®?
get access -
Not a Newsday
or Optimum Online®
subscriber?
click here
